SCHEMBL30107820

SCHEMBL30107820

Fc1ccc2c(c1)c1cc(F)ccc1n2-c1cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc(-n2c3ccc(F)cc3c3cc(F)ccc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.42
MAPT P10636 5/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NTSR1 P30989 1/20 0.40
KDM4E B2RXH2 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
CYP19A1 P11511 1/20 0.37
NR3C1 P04150 1/20 0.37
ADORA2A P29274 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107821 0.96 DHODH (0.40) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL30107873 0.96 MEN1 (0.42) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL30107890 0.92 MAPT (0.39) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL30107773 0.92 MAPT (0.42) MAPTL3MBTL1HTTJAK2JAK3
SCHEMBL8400369 0.89 JAK2 (0.44) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL15887934 0.89 MAPT (0.40) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL15887854 0.89 MAPT (0.40) DHODHMAPTL3MBTL1MAPK1HTT
SCHEMBL30107877 0.88 KDM4E (0.41) MAPTL3MBTL1JAK2JAK3MEN1
SCHEMBL30107851 0.86 MEN1 (0.45) DHODHMAPTL3MBTL1MAPK1NPSR1
SCHEMBL30107714 0.86 MEN1 (0.45) DHODHMAPTL3MBTL1MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 DHODH 1052/4885MAPT 166/4885L3MBTL1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.